Patient NAME : Mr Daiwik Mahajan

DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report

Patient ID / UHID : 10970429/RCL10187175 Barcode NO : HR093222
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:36 PM.
Test Description Value(s) Unit(s) Reference Range

Bajaj - PHC CLASSIC

Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 14.6 g/dL 13.0 - 17.0
colorimetric
RBC Count 5.2 10^6/µl 4.5 - 5.5
Electrical impedance
PCV 44.3 % 40 - 50
Calculated
MCV 85.1 fl 83 - 101
Calculated
MCH 28.1 pg 27 - 32
Calculated
MCHC 33.1 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 14.4 % 11.6 - 14.0
Calculated
RDW-SD * 44 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 7.8 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 60 % 40-80
Lymphocytes 28 % 20-40
Monocytes 8 % 2-10
Eosinophils 4 % 1-6
Basophils 0 % <2
Absolute Leukocyte Counts
Neutrophils. 4.68 10^3/µl 2-7
Lymphocytes. 2.18 10^3/µl 1-3
Monocytes. 0.62 10^3/µl 0.2 - 1.0
Eosinophils. 0.31 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 291 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 10.1 fL 9.3 - 12.1
Calculated
PCT * 0.3 % 0.17 - 0.32
Calculated

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 1 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : HR093222
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:36 PM.
Test Description Value(s) Unit(s) Reference Range
PDW * 12.1 fL 8.3 - 25.0
Calculated
P-LCR * 26.5 % 18 - 50
Calculated
P-LCC * 77 10^9/L 44 - 140
Calculated
Mentzer Index * 16.37 % > 13
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 2 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : HR093222
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 02:50 PM.
Test Description Value(s) Unit(s) Reference Range

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 7 mm/hr 0 - 20

MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 3 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : HR093222
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 04:29 PM.
Test Description Value(s) Unit(s) Reference Range

HbA1C (Glycosylated Haemoglobin)

Glycosylated Hemoglobin (HbA1c) 5.7 % < 5.7

HPLC
Estimated Average Glucose 116.89 mg/dL Refer Table Below
Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 4 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967966
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 12:48 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 117 mg/dL 70 - 100

GOD-POD

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels (hyperglycemia)
may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders. Decreased glucose
levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 5 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:15 PM.
Test Description Value(s) Unit(s) Reference Range

Blood Urea Nitrogen (Bun)

Blood Urea 30.4 mg/dL 19 - 45

Urease-GLDH
Bun * 14.21 mg/dL 6 - 20
Urease

Interpretation:
1. The blood urea nitrogen (BUN) test measures the amount of nitrogen in your blood that comes from the waste product urea. Urea is formed
in the liver when the body breaks down proteins and is eventually eliminated by the kidneys.

2. Low BUN levels can be caused by a variety of factors. Liver disease is a primary cause, as urea is produced in the liver, and any dysfunction
in this organ can lead to lower BUN levels. Malnutrition or a low protein diet can also contribute, as inadequate protein intake reduces urea
production. Overhydration, resulting from excessive fluid intake, can dilute the urea concentration in the blood. Additionally, pregnancy can lower
BUN levels due to increased fluid retention and changes in metabolism.

3. High BUN levels can result from various conditions. Kidney dysfunction is a primary cause, as impaired kidney function can reduce urea
elimination. Dehydration, which decreases fluid volume in the body, can also concentrate urea. A high protein diet can increase urea production
due to excessive protein intake. Heart failure can reduce blood flow to the kidneys, impairing their function. Gastrointestinal bleeding contributes
to high BUN levels by breaking down blood proteins in the digestive tract. Certain medications, such as corticosteroids and antibiotics, can
elevate BUN levels. Additionally, shock or severe stress can affect BUN levels by reducing blood flow to the kidneys.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 6 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:15 PM.
Test Description Value(s) Unit(s) Reference Range

Creatinine

Creatinine 0.7 mg/dL 0.7 - 1.3

Enzymatic
eGFR (CKD-EPI) 141.29 ml/min/1.73 sq m Normal Or High: >= 90
Mild Or Decrease: 60-89
Mild To Moderate Decrease:
45-59
Mild To Severe Decrease:
30-44
Severe Decrease: 15-29
Kidney Failure: < 15
Interpretation:
Creatinine estimation is done to assess kidney function. It is not dependent on dietary factors. Normal values are obtained in kidney diseases,
except in advanced renal failure and therefore its estimation is more valuable if coupled with clearance.

"eGFR test is applicable for patients aged 18 years or more."

Liver Function Test (LFT)

Bilirubin Total 0.8 mg/dL 0.0 - 2.0

Diazo
Bilirubin Direct * 0.4 mg/dL 0.0 - 0.4
Gerarde
Bilirubin Indirect * 0.4 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 11.9 U/L up to 35
IFCC WITHOUT PYRIDOXALPHOSPHATE
SGPT/ALT 13.9 U/L up to 45
IFCC WITHOUT PYRIDOXALPHOSPHATE
SGOT/SGPT Ratio * 0.86 - -
Alkaline Phosphatase 212 U/L 53 - 128
AMP
Total Protein 6.72 g/dL 6.4 - 8.3
Biuret
Albumin 3.95 g/dL 3.2 - 4.5
BCG
Globulin * 2.77 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.43 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 15.2 U/L 5 - 40
Glupa C

Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 7 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:15 PM.
Test Description Value(s) Unit(s) Reference Range
clotting proteins, and performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical
reactions. When liver cells are damaged or destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood
tests Liver tests check the blood for two main liver enzymes. Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in
muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is almost exclusively found in the liver. If ALT
and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase and GGT: Another of
the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline
phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is
by far the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile
flow problems can be due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all
cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood contains two classes of protein, albumin and
globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your immune system. Low
total protein may

Indicate:
1.Bleeding
2.Liver disorder
3.Malnutrition
4.Agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive
water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low
albumin levels may be

Caused by:
1.A poor diet (malnutrition).
2.Kidney disease.
3.Liver disease. High albumin levels may be caused by: Severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 8 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:15 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 131 mg/dL <200

CHOD-PAP
Triglycerides 85.3 mg/dL <161
GPO
HDL Cholesterol 36.8 mg/dL 35.3 - 79.5
Selective Detergent
Non HDL Cholesterol * 94.2 mg/dL <130
Calculated
LDL Cholesterol * 77.14 mg/dL <100
Calculated
V.L.D.L Cholesterol * 17.06 mg/dL < 30
Calculated
Chol/HDL Ratio * 3.56 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.48 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 2.1 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 9 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:15 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors

Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors

1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 10 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 01:15 PM.
Test Description Value(s) Unit(s) Reference Range

Calcium

Calcium Serum 9.7 mg/dL 8.6 - 10.2

Arsenazo

Interpretation:
Elevated calcium value are associated with hyperparathyrodism, multiple myeloma, neoplasms of bone and parathyroid & conditions of rapid
demineralization, tetany & occasionally with nephrosis & pancreatitis. Severe nephritis & uremia may cause either elevated or lowered calcium
values. Decreased values of calcium are noted in hypoparathyroidism, vitamin D deficiency, renal insufficiency, hypoproteinemia, malabsorption
syndrome, severe pancreatitis with pancreatic necrosis and pseudo-hypoparathyroidism.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 11 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 03:34 PM.
Test Description Value(s) Unit(s) Reference Range

Thyroid Profile Total

Triiodothyronine (T3) 174.6 ng/dL 35 - 193

ECLIA
Total Thyroxine (T4) 7.39 µg/dL 4.87 - 11.2
ECLIA
Thyroid Stimulating Hormone (Ultrasensitive) 2.44 mu/mL 0.51–4.30
ECLIA

Interpretation:
Pregnancy Reference ranges TSH
1st Trimester 0.1 - 2.5
2nd Trimester 0.2 - 3.0
3rd Trimester 0.3 - 3.0

Note:
TSH levels are subject to circadian variation, reaching peak levels between 2-4 am. and at a minimum between 6-10 pm. The variation is
of 50 %, hence time of the day has influence on the measured serum TSH concentrations.

Clinical Use:
- Diagnose Hypothyroidism and Hyperthyroidism
- Monitor T4 replacement or T4 suppressive therapy
- Qunatify TSH levels in the subnormal range

Increased Levels : Primary hypothyroidism, Subclinical hypothyroidis, TSH dependent Hyperthyroidism, Thyroid hormone resistance
Decreased Levels: Grace disease, Autonomous thyroid hormone secretion, TSH deficiency

Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH
directly affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any
portion of the thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism,
TSH levels are significantly elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the
Euthyroid Sick Syndrome, multiple alterations in serum thyroid function test findings have been recognized in patients with a wide
variety of non-thyroidal illnesses (NTI) without evidence of preexisting thyroid or hypothalami c-pitutary diseases. Thyroid Binding
Globulin (TBG) concentrations remain relatively constant in healthy individuals. However, pregnancy, excess estrogen's, androgen's,
antibiotic steroids and glucocorticoids are known to alter TBG levels and may cause false thyroid values for Total T3 and T4 tests.

TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
Low or
High Low Hypothyroidism
Normal
Low Normal Normal Mild (subclinical) hyperthyroidism
High or High or
Low Hyperthyroidism
normal normal
Low or Low or
Low Nonthyroidal illness; pituitary (secondary) hypothyroidism
normal normal
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 12 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : ZF967965
Referred BY : Self Sample Type : Serum
Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 03:34 PM.
Test Description Value(s) Unit(s) Reference Range

Thyroid hormone resistance syndrome (a mutation in the thyroid hormone

Normal High High
receptor decreases thyroid hormone function)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 13 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : YB620461
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 12:13 PM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 20 mL -
Colour * Pale yellow - Pale yellow
Transparency * Clear - Clear
Deposit * Absent - Absent
Chemical Examination
Reaction (pH) 6.0 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.025 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Negative - Negative
Acid / Base Colour Excahnge
Urine Ketones (Acetone) Negative - Negative
Legals Test
Blood Negative - Negative
Peroxidase Hemoglobin
Leucocyte esterase Negative - Negative
Enzymatic Reaction
Bilirubin Urine Negative - Negative
Coupling Reaction
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 1-2 /hpf 0-5
Epithelial Cells * 1-2 /hpf 0-4
Red blood Cells * Absent /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria * Absent - Absent
Protozoa * Absent - Absent
Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 14 of 15
 Patient NAME : Mr Daiwik Mahajan
DOB/Age/Gender : 13 Y/Male Report STATUS : Final Report
Patient ID / UHID : 10970429/RCL10187175 Barcode NO : YB620461
Referred BY : Self Sample Type : Spot Urine
Sample Collected : Jan 06, 2025, 10:14 AM Report Date : Jan 06, 2025, 12:13 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and bleeding
disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- BAJAJ_FINSERV NOIDA, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., 4B2 Basement & Ground Floor, Tilak Nagar, New Delhi-110018.

Page 15 of 15
 HOW WAS YOUR EXPERIENCE?
We value your feedback, please scan with your phone camera
and rate overall experience.

How likely are you to recommend Redcliffe Labs to your family & friends

Not Likely Very Likely

Scan with your phone camera